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ABSTRACT Oxidation and reduction (redox) are known to modulate the function of a variety of ion channels. Here, we report
a redox regulation of the function of ClC-0, a chloride (Cl) channel from the Torpedo electric organ. The study was motivated
by the occasional observation of oocytes with hyperpolarization-activated Cl- current when these oocytes expressed ClC-0. We
ﬁnd that these atypical recording traces can be turned into typical ClC-0 current by incubating the oocyte in millimolar
concentrations of reducing agents, suggesting that the channel function is regulated by oxidation and reduction. The redox
control apparently results from an effect of oxidation on the slow (inactivation) gating: oxidation renders it more difﬁcult for the
channel to recover from the inactivated states. Introducing the point mutation C212S in ClC-0 suppresses the inactivation state,
and this inactivation-suppressed mutant is no longer sensitive to the inhibition by oxidizing reagents. However, C212 is probably
not the target for the redox reaction because the regulation of the inactivation gating by oxidation is still present in a pore mutant
(K165C/K165 heterodimer) in which the C212S mutation is present. Taking advantage of the K165C/K165 heterodimer, we
further explore the oxidation effect in ClC-0 by methane thiosulfonate (MTS) modiﬁcations. We found that trimethylethy-
lammonium MTS modiﬁcation of the introduced cysteine can induce current in the K165C/K165 heterodimer, an effect attributed
to the recovery of the channel from the inactivation state. The current induction by MTS reagents is subjected to redox controls,
and thus the extent of this current induction can serve as an indicator to report the oxidation state of the channel. These results
together suggest that the inactivation gating of ClC-0 is affected by redox regulation. The ﬁnding also provides a convenient
method to ‘‘cure’’ those atypical recording traces of ClC-0 expressed in Xenopus oocytes.
INTRODUCTION
The members of the ClC family transport Cl ions across cell
membranes and play important roles in various physiological
functions, including regulation of the membrane potential,
transepithelial Cl transport, and, in the case of bacteria, the
resistance to acidic environments (Jentsch et al., 1999, 2002;
Maduke et al., 2000; Iyer et al., 2002; Accardi and Miller,
2004). The structural architecture of the transmembrane
domains of these molecules has recently been suggested
from the crystal structure of two bacterial ClC homologs
(Dutzler et al., 2002, 2003). Signiﬁcant conservation of the
functionally important channel sequences among ClC family
members suggests that the structure of bacterial ClCs may
serve as a model for understanding the structure and function
of vertebrate ClC channels (Chen and Chen, 2003; Lin and
Chen, 2003). Indeed, the presence of two ion-transport
pathways in these family members, which was predicted two
decades ago based on functional electrophysiological studies
carried out in the Torpedo ClC-0 channel (Miller, 1982;
Hanke and Miller, 1983; Miller and White, 1984), was
conﬁrmed by the bacterial ClC structure.
Although high-resolution structures of bacterial ClC
proteins provided a rich suggestion for vertebrate ClC
channel functions, recent studies showed that the bacterial
ClC protein is not an ion channel but a transporter (Accardi
et al., 2004; Accardi and Miller, 2004). This ﬁnding indicates
that studying vertebrate ClC channels is necessary for
understanding the channel functions, namely the gating and
permeation properties of these proteins. For functional
studies of ClC channels, Xenopus oocytes have been widely
used, and ClC-0 is the best-studied member of the entire ClC
family. However, in expressing this prototypic member of
the ClC family in Xenopus oocytes, we encounter a wide
spectrum of current recording traces. Fig. 1 illustrates the
variation of current obtained from two-electrode voltage-
clamp recordings. Frequently, typical ClC-0 current traces
such as those shown in the literature are obtained, with
a characteristic ‘‘crossover’’ at the negative voltage range
(Fig. 1, left). However, it is also quite common to encounter
oocytes expressing atypical current, which normally would
have been considered ‘‘bad’’ oocytes without ClC-0 current
(Fig. 1, middle). Between these two extremes, there are also
oocytes that produce the ClC-0-like current at depolarized
potentials, but when the membrane potentials are negative
enough—for example, 140 or 160 mV—the hyperpolar-
ization-activated current appears as if the recorded current is
contaminated by the leak current or by the endogenous
oocyte channels (Fig. 1, right).
Because Xenopus oocytes are valuable for functional
studies of ClC channels, we were motivated to investigate
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the variation of the ClC-0 current. We discovered by
serendipity that such a variation was largely due to the
oxidation state of the oocyte. Oxidation of oocytes by
externally applied copper phenanthroline (CuPhe) not only
rendered the ClC-0 current traces atypical, but also led to
an inhibition of the current. On the other hand, incubating
the oocytes in b-mercaptoethanol (b-ME) or dithiothretol
(DTT) turned atypical ClC-0 recordings into typical traces.
Oxidation and reduction are known to affect the functions of
many proteins, including ion channels (Feng et al., 2000;
Pessah and Feng, 2000; Xia et al., 2000; Tang et al., 2001;
Zeidner et al., 2001). To understand more about this redox
effect, we ﬁrst examined whether any of the 12 endogenous
cysteine residues in ClC-0 could be the target of oxidation
and reduction. We found that mutation of an inactivation-
suppressed mutant C212S (Lin et al., 1999) is resistant to the
oxidation inhibition by CuPhe. However, a heterodimeric
mutant, K165C/K165, which was constructed in the C212S
mutation background, also exhibited a prominent regulation
by oxidation. Thus, it is likely that the oxidation causes the
channel to stay in the deep inactivation state. Experiments
using methane thiosulfonate (MTS) reagents to modify the
introduced cysteine in the K165C/K165 heterodimer are also
consistent with this assertion, because the more inactivated
the channel, the more current is induced by MTS reagents.
MATERIALS AND METHODS
Mutagenesis and channel expression
The wild-type (WT) and mutant ClC-0 were all constructed in the
expression vector pBluescript. The construction of the K165C/K165
heterodimer in the background of the C212S mutation was described
previously (Lin and Chen, 2000). Construction of the other heterodimers
followed the same approach. Brieﬂy, the two monomers (that is, K165C/
C212S and C212S) were linked together by proper restriction sites, with
four amino acid residues (GTTS) inserted between (Lin and Chen, 2000).
No appreciable difference between the two versions of the heterodimer
(e.g., K165-K165C or K165C-K165) was noticed. Thus, they will simply
be called ‘‘K165C heterodimer’’ in the following text. For the other
various cysteine mutants, the WT ClC-0 constructed in pBluescript vector
was used as a mother plasmid. Mutations of the 12 endogenous cysteines
(single, double, or triple mutants) were made using PCR mutagenesis ap-
proaches. All mutations were conﬁrmed by commercially available DNA
sequence services. Synthesis of RNAs from the cDNA constructs and the
injection of RNAs into Xenopus oocytes were performed according to
previously described methods (Chen, 1998; Lin et al., 1999; Lin and Chen,
2000).
Preparation of the sulfhydryl reactive reagents
DDT and b-ME were purchased from Pharmacia Biotech (Piscataway, NJ)
and Bio-Rad (Hercules, CA), respectively. For the oxidizing reagents,
CuPhe was made by mixing 150 mM CuSO4 with 500 mM 1,10-
phenanthroline (Sigma Chemical, St. Louis, MO) in 1:4 ethanol/water
mixture (Fahlke et al., 1998). Hydrogen peroxide (H2O2) was from EM
Science/Merck (Darmstadt, Germany). After RNA injection, oocytes were
kept in a high Ca21ND96 solution of (in mM) 96 NaCl, 2 KCl, 1 MgCl2, 1.8
CaCl2, and 5 HEPES, pH 7.5. To manipulate the oxidation or reduction
conditions of the oocytes, the oxidizing and reducing reagents were directly
added to the incubation buffer. Upon recording, the redox controlling
reagents were removed by transferring the oocytes to a fresh ND96 medium.
For oocytes in the mildly oxidized condition, no redox reagent was added to
the incubation buffer. As shown in Results, and by others (Gross and
MacKinnon, 1996; Zeidner et al., 2001), the plain ND96 solution has a mild
oxidizing capability.
MTS reagents were purchased from Toronto Research Chemicals (North
York, Ontario). Stock solutions of 0.1–0.3 M were prepared in distilled
water and stored at70C. The working solutions containing indicated con-
centrations of the MTS reagents were made immediately before use.
Macroscopic current recordings
Whole-oocyte currents were measured by a two-electrode, voltage-clamp
ampliﬁer (725C, Warner Instruments, Hamden, CT). Control of the
membrane potential and data acquisition were performed by a Pentium PC
computer equipped with Digidata 1200 analog interface, using pClamp6
software (Axon Instruments, Union City, CA). The standard recording
(extracellular) solution was ND96 solution, containing (in mM) 96 NaCl,
2 KCl, 1 MgCl2, 0.3 CaCl2, and 5 HEPES, pH 7.5. Except where indicated,
two voltage protocols were used throughout the study. In one (protocol 1),
the membrane potential of the oocyte was clamped at 30 mV, and the
current was monitored with a 140-mV voltage step for 50 or 100 ms
followed by a 150-mV voltage step for 100 ms. Since the fast gate of the
channel usually has an open probability close to unity at the voltage of
FIGURE 1 Variations of the ClC-0 current in
different oocytes. Three oocytes that were not
pretreated with oxidizing or reducing reagents were
recorded using protocol 2. Test voltages were
from 180 mV to 160 mV in 20-mV steps. The
120 mV voltage step was shown only for the ﬁnal
10–20 ms. On the left are typical ClC-0 current
traces, with the ﬁrst crossover occurring between
80 and 100 mV. The traces in the middle and
right panels are oxidized: the current is small and
a short pulse (125 ms) at 140 or 160 mV
activated the current. On the other hand, for the
typical recordings (left), the same negative voltage
pulse that was twice as long did not elicit the
hyperpolarization-induced current, indicating that
most of the channels were not in the deep inactivated state during the recording. After treatment of these three oocytes with b-ME, the current measured at
180 mV in the middle and right panels increases to ;10 and 13 mA, respectively, whereas the current shown in the left panel did not increase.
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140 mV, protocol 1 is convenient to monitor the slow gating of ClC-0 in
a continuous recording. The voltage pulses were given once every 2, 4, or 6 s.
The higher the pulse frequency was (the more time the channel experienced
the negative voltage, 150 mV), the faster was the recovery of the channel
from the inactivation state. The oocyte current at the end of the 140-mV
voltage step was used to monitor the slow-gating process.
Examination of the fast-gate open probability (Po) from macroscopic
current recordings followed a protocol (protocol 2) that applied a family of
different voltage steps to the oocyte (Chen, 1998; Lin et al., 1999; Lin and
Chen, 2000). To start this voltage protocol, the current of the oocyte was ﬁrst
activated by protocol 1. Usually, it took ;50 pulses (given once every 2 s)
for the slow gating to reach a steady state (see Fig. 2 C). Protocol 2 (see Fig.
2, B andD) started with a negative voltage step of120 mV for 100–200 ms
to further ensure the opening of the slow gate. A positive prepulse (at160 or
180 mV) was then given to open the fast gate, followed by different test
voltages from 160 or 180 mV to 160 mV in 20-mV steps. The tail
current was measured at 100 mV, and the extrapolated value to the
beginning of the tail current was normalized to that obtained after the most
depolarized test pulse.
Except for the experiments shown in Fig. 6 B (see Fig. 6), all record-
ings were conducted at room temperature (;20–24C). In Fig. 6 B, the
temperature control was made by preincubating the solution in a water bath
set at the same temperature as the adjusted room temperature. The tem-
perature of the solution in the recording chamber was measured by a small
temperature-sensitive element connected to a heater controller (TC324A;
Warner Instruments).
For the experiments involving solution exchanges, the solutions
containing the required reagents (such as MTS reagents, b-ME, or CuPhe)
were made immediately before use. The volume of the recording chamber
was ;1 ml, and the ﬂow rate of the solution was usually more than 15–
20 ml/min, making the solution exchange time constant,5 s. The effects of
b-ME and CuPhe were much slower than the solution exchange speed. In
the current-induction experiments by 2-aminotheyl MTS (MTSEA) or
trimethylethylammonium MTS (MTSET), the concentrations of the MTS
reagents were chosen to give an apparent induction time constant at least
ﬁvefold larger than the solution exchange time.
Data analysis
An archive of electrophysiological experiments has shown that ClC-0
contains two identical pores, as suggested from the three equally spaced
current levels in single-channel recording traces (Miller, 1982; Hanke and
Miller, 1983; Miller and White, 1984; Bauer et al., 1991; Chen and Miller,
1996; Ludewig et al., 1996; Middleton et al., 1996; Saviane et al., 1999; Lin
and Chen, 2000; Chen and Chen, 2003). These two pores are regulated by
two gating mechanisms, fast gating and slow gating. At the macroscopic
current level, the fast gating is represented by the current relaxation at the
millisecond time range, as shown by the current deactivation at the negative
voltage range in Fig. 1 (left). This current deactivation results from a decrease
of the fast-gate Po upon membrane hyperpolarization. On the other hand, the
slow-gate opening is favored when the membrane potential is hyper-
polarized (Pusch et al., 1997; Chen, 1998). Thus, in an experiment using
protocol 1, the current at 140 mV will gradually increase because the
channel recovers from the inactivation state when the oocyte experiences
the negative potential (150 mV) in each voltage sweep. With protocol 2,
the reduction of fast-gate Po at large negative voltages usually surpasses the
increase of the driving force for permeant ions, resulting in ‘‘typical’’
recording traces (Fig. 1, left) with a characteristic ‘‘crossover’’ at the
negative voltage range (Pusch et al., 1995; Ludewig et al., 1996; Chen,
1998; Maduke et al., 1998; Chen and Chen, 2001).
To compare the recorded current we adopted an empirical method that
quantiﬁes the pattern of the recording traces. From the current traces
activated by protocol 2, we measured the steady-state current at the most
depolarized voltage (160 or180 mV) and counted the number of traces that
crossed the one obtained at the 20-mV, more depolarized voltage. For
example, the crossover numbers for recordings in Fig. 1 (left, middle, and
right) are 4, 0, and 0, respectively. In our entire set of data performed in
;100 mM extracellular Cl, the largest crossover number is 4. Since each
voltage step differs by 20 mV, and the most hyperpolarized voltage step in
protocol 2 is 160 mV, the ﬁrst crossover occurs between the trace at 80
and that at100 mV, or at more hyperpolarized voltages when the recording
traces become atypical.
Statistical information was collected using Origin software (OriginLab,
Northampton, MA). The results in Table 1, and the average value in Figs. 3
FIGURE 2 Effect of b-ME on the oxidizedWT ClC-
0 current. Whole-oocyte current was compared before
(A and B) and after (C and D) 5 mM b-ME treatment
for 1 h. Temperature was ;20C. (A) Time course of
current activation by protocol 1, with one pulse every
2 s. The current at the end of 160 mV (s) and 150
mV (d) are plotted against time. The recording traces
within the inset box are taken from 0-, 58-, and 118-s
time points, respectively. The oocyte current did not
increase signiﬁcantly, even though a150 mV voltage
step for 100 ms was applied every 2 s. (B) After the
recordings in A, the same oocyte was immediately
evaluated with protocol 2, with the test voltages from
160 mV to 160 mV in 20-mV steps. (C and D)
Whole-cell current of the same oocyte as that examined
in A and B after the oocyte was treated with b-ME. The
experimental manipulations in C and D were the same
as those in A and B, respectively. Current traces in the
inset box are the same time points as those described in
A. Notice that the current measured at 140 mV is
monotonically increased to a much higher level by the
150 mV voltage step (see sin C), and the current
deactivation at negative potentials is prominent,
resulting in the typical crossover of the recording
traces at negative voltages (see recording traces at
120, 140, and 160 mV in D).
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and 4 A, are given as mean 6 SD to better show the distribution of the
values. All other results are presented as mean 6 SE.
RESULTS
Redox control of WT ClC-0 current
The expression of WT ClC-0 in Xenopus oocytes is robust in
that Cl current is usually observed 24–48 h after mRNA
injection. The pattern of the whole-oocyte current, however,
is highly variable from different batches of oocytes, and
sometimes even within the same batch of oocytes. In some
recordings, the current is outwardly rectiﬁed at steady state,
with deactivation when the membrane potential is stepped to
a negative voltage, as expected from the voltage dependence
of fast-gate open probability (Fig. 1, left). It is, however,
quite common to encounter mRNA-injected oocytes with
currents that appear to be contaminated by the endogenous
hyperpolarization-activated current (Fig. 1, middle and
right). Such an atypical ClC-0 current can be converted
into the typical ClC-0 current by incubating oocytes in
reducing reagents, as illustrated by the experiments shown
in Fig. 2. For this experiment, the oocyte was incubated in
ND96 without reducing reagents, and was recorded 2 days
after mRNA injection. This oocyte had a very small outward
current, and a short (100-ms) negative pulse to 150 mV
was long enough to activate a hyperpolarization-induced
current (Fig. 2 A, inset). Delivering a voltage family (from
160 to 160 mV) using protocol 2 did not elicit current
traces crossing each other (Fig. 2 B). After the experiments
shown in Fig. 2, A and B, the same oocyte was incubated in
5 mM b-ME for 1 h, and the same voltage protocol activated
a very different pattern of current traces. With a 100-ms
voltage pulse to 150 mV continuously applied at 0.5 Hz,
the outward current (and also the instantaneous inward
current) was gradually activated (Fig. 2 C). Using protocol 2,
the activated current showed the hallmark of crossover at
negative voltages (Fig. 2 D). These experiments indicate that
oxidation and reduction of the oocyte may affect the function
of the WT ClC-0.
The different patterns in the WT ClC-0 current expressed
in Xenopus oocytes appeared to come from natural variation,
most likely related to the quality of oocytes. The most
atypical current (at 180 mV) was usually small, and there
was no crossover of traces at negative voltage ranges. The
typical recordings, on the other hand, usually revealed 3–4
crossovers in our recording conditions. There were also
recordings with 1–2 crossovers, and they were considered as
intermediate recordings between the typical and atypical
traces. Table 1 lists a summary of WT ClC-0 current before
and after a 1-h treatment with 5 mM b-ME in oocytes taken
from 14 frogs. If the number of crossovers or the mean
current increases after b-ME treatment, we consider that the
oocytes might at least be partially oxidized. Overall, the
oocytes from freshly adopted frogs produced oxidized
current only occasionally. However, after the frogs were
kept for several months, it appeared that more oocytes
expressed atypical current (Table 1).
As the atypical current can be converted into typical
recordings by b-ME, we suspect that oxidation may confer
an opposite effect; that is, converting the typical ClC-0
current into atypical traces. Fig. 3 A (left) shows the
TABLE 1 Variation of the WT ClC-0 current activated by protocol 2












1 25 2.3 6 1.0 11.7 6 7.6 3.1 6 0.8* 13.0 6 8.9
2 7 3.4 6 0.5 20.7 6 5.3 3.4 6 0.5 23.3 6 7.2
3 10 2.9 6 1.1 8.5 6 4.4 3.4 6 0.5 10.4 6 4.2
4 12 3.2 6 0.4 17.7 6 6.7 3.3 6 0.5 20.1 6 6.9
5 9 3.2 6 0.4 11.6 6 4.1 3.2 6 0.4 14.6 6 4.2
6y 16 2.0 6 1.3 14.0 6 4.7 2.8 6 0.8* 19.2 6 6.1*
7y 16 1.9 6 1.0 7.6 6 3.8 3.1 6 0.8* 14.9 6 5.5*
8 17 3.4 6 0.6 14.8 6 3.6 2.8 6 0.7 21.1 6 4.7*
9 22 3.6 6 0.6 9.4 6 3.0 N.D. N.D.
10 24 3.1 6 0.5 11.7 6 3.8 N.D. N.D.
11y 14 0.1 6 0.3 2.5 6 1.1 2.9 6 0.9* 10.6 6 2.8*
12y 15 0.3 6 0.5 1.7 6 0.7 3.5 6 1.1* 3.9 6 1.5*
13y 4 0.3 6 0.5 7.5 6 4.3 2.3 6 1.0* 9.4 6 4.3*
14y 20 3.1 6 0.6 8.4 6 3.4 3.4 6 0.7 11.9 6 3.7*
Test voltages were from 160 or 180 mV to 160 mV in 20-mV steps. The same oocyte was recorded before and after a 1-h treatment with 5 mM b-ME.
The number of trace crossovers and the current from the most depolarized voltage are shown. Frogs 1–7 were operated for the ﬁrst time, whereas frogs 8–14
had received at least one surgery before the oocytes were harvested.
*A statistical difference (pair t-test, p , 0.01) from the control value obtained before b-ME treatment, suggesting that the oocytes might be at least partially
oxidized.
yFrogs that had been kept longer than 3 months before oocytes were harvested.
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recording of an oocyte that has been pretreated with reducing
agents. There are three crossovers in this recording at 120,
140, and 160 mV (traces at these three voltages cross
with those at 100, 120, and 140 mV, respectively).
After this recording, the same oocyte is subjected to
oxidation in the presence of 10 mM CuPhe. In 1 h, ;70%
of the current is inhibited, and the recordings do not show
any crossover (Fig. 3 A,middle). Application of 5 mM b-ME
on the same oocyte then completely recovers the current
(Fig. 3 A, right). The average number of crossovers and the
current amplitude at 180 mV in 20 oocytes (from three
frogs) are also shown for each condition. It can be seen that
10 mM CuPhe treatment invariably inhibits the current.
Furthermore, none of the 20 CuPhe-treated oocytes shows
any crossover of recording traces (Fig. 3 A, middle).
Because the ClC-0 inactivation gating is known to be
facilitated by extracellular zinc ions (Chen, 1998), it might
be possible that the inhibition by CuPhe does not come from
an effect of oxidation but from a direct effect of copper ions
in facilitating the slow gating of the channel. To assure that
the effect was not simply from copper ions, we conducted
control experiments in which the oxidation power of 10 mM
CuPhe was removed while copper ions were present in
the incubation buffer. Incubating oocytes in the mixture
of CuPhe and b-ME, though resulting in a slight decrease of
current at 180 mV, has no effect on the number of
crossovers (Fig. 3 B). Treating oocytes with 10 mM copper
sulfate (CuSO4) for 1 h does not result in alterations of the
crossover number and the open channel current (Fig. 3 C).
Using a metal-ion-free reagent, H2O2, on the other hand,
gives a similar oxidation effect as that produced by CuPhe.
FIGURE 3 Oxidation effects on the WT ClC-0. (A) Effects of 10 mM
CuPhe on ClC-0. All current traces in the left, middle, and right panels were
from the same oocyte. Recordings on the left were made after the oocyte was
treated with 5 mM b-ME for 1 h. Recordings in the middle were made after
the oocyte was treated with 10mMCuPhe. At right are recordings made after
the oocyte was again treated with 5 mM b-ME after the CuPhe treatment.
The number of crossovers and the current at the most depolarized voltage
(both presented as mean 6 SD) for 20 oocytes are shown. The asterisks
indicate a signiﬁcant difference from the corresponding value on the left
panel (pair t-test with the signiﬁcance level at p ¼ 0.01). (B) Recordings of
WT ClC-0 in another 19 oocytes. The recording procedure was the same as
that shown in A, except that the recordings in the middle panel were made
after 1 h of treatment with 10 mM CuPhe 1 5 mM b-ME. (C) Effects of
CuSO4 on WT ClC-0. The recording procedure was the same as that shown
in A and B, except that the recordings in the middle panel were made after 1 h
of treatment with 10 mMCuSO4 (n¼ 7). (D) Effects of H2O2 on WT ClC-0.
The experimental procedure was the same as those shown in A–C, except
that the recordings in the middle panel were made after 1 h of treatment with
0.01% H2O2 (n ¼ 5).
FIGURE 4 Effects of CuPhe on various cysteine mutants of ClC-0. (A)
Effects of CuPhe on C212S mutant. The oocyte was not pretreated with
b-ME before the recording shown on the left. The recording on the right was
made after the same oocyte was treated with 10 mM CuPhe for 1 h. From
nine oocytes, the number of crossovers and the current at160 mV were also
shown (mean 6 SD). There is no statistical difference before and after
CuPhe at a signiﬁcant level of p ¼ 0.01 (pair t-test). (B) Effects of CuPhe on
various mutants of ClC-0. The endogenous cysteine residues were mutated
as indicated. The oocyte current was compared before and after 10 mM
CuPhe treatment for 1 h using protocol 2. The current amplitude at the
most depolarized voltage (160 or 180 mV) after CuPhe treatment was
normalized to the current before CuPhe. The data of WT channels were from
a different set of oocytes from that shown in Fig. 3 A.
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Incubating oocytes in 0.01% H2O2 for 1 h suppresses WT
ClC-0 current by nearly 70%, and reduces the number of
crossovers as well (Fig. 3 D).
Inactivation-suppressed mutant C212S
is insensitive to oxidation
The inhibition of the WT current by oxidizing reagents
occurs slowly, and the oxidized channel appears to be more
difﬁcult to activate by hyperpolarization (Fig. 2). This
suggests that oxidation may render it more difﬁcult for the
channel to recover from the inactivation state. If this is the
case, we expect that oxidation will have a small effect, or
even no effect, on the channel whose slow (inactivation) gate
is locked open. The inactivation-suppressed mutant C212S
(Lin et al., 1999) usually shows current traces with three to
four crossovers at negative voltages (Fig. 4 A, left). To
examine the oxidation effect on the C212S mutant, we
applied 10 mM CuPhe to the oocyte. Fig. 4 A (right) shows
that the C212S mutant is resistant to the inhibition of 10 mM
CuPhe. With a 15-fold higher concentration (150 mM),
,10% of the current was inhibited in 1 h (data not shown).
To further examine whether any of the other 11
endogenous cysteine residues in the WT ClC-0 was also
important for the redox control described here, we tested
the sensitivity of various cysteine mutants to the CuPhe
inhibition. Fig. 4 B summarizes the effect of oxidation
(10 mM CuPhe for 1 h) on the mutants in which single or
multiple endogenous cysteine residues were mutated. Except
for the mutants including the C212 mutation (C212S single
mutant or the C212A/C213A/C229S triple mutant), all the
cysteine mutants showed sensitivity to CuPhe inhibition
approximately similar to that of theWT channel. On the other
hand, mutants lacking a cysteine at position 212 appeared to
be resistant to the inhibition by oxidizing reagents.
C212 is probably not the target for the redox
effect on the inactivation gating
To understand the functional role of C212 in the aforemen-
tioned redox control on the channel’s function, we studied
the effects of CuPhe and b-ME on several C212S-related
mutants (Fig. 5). If the resistance of C212S to CuPhe was
due to a prevention of disulﬁde-bond formation between the
two C212 residues, a C212-C212S heterodimer should also
be resistant to CuPhe inhibition. This, however, was not the
case (Fig. 5 A). Another mutant, the K165C heterodimer in
the presence of C212S background mutation, provides
further insight into the role of C212S mutation. This mutant
was shown to have prominent inactivation gating, although
the C212 residue was replaced with serine in both subunits
(Lin and Chen, 2000). In Fig. 5 B (upper left), an oocyte
expressing the K165C heterodimer (with C212S back-
ground) was ﬁrst incubated in 5 mM b-ME for more than
2 h. The oocyte was then transferred to the recording
chamber, and the current was monitored by pulsing protocol
1. The current measured at 140 mV was slowly decreased
when b-ME was removed from the bath, indicating an
oxidation capability of the plain ND96 solution. The
FIGURE 5 Redox control of the C212S-related mutants. (A) Effects of
CuPhe on the C212-C212S heterodimer. Recordings at left were made
before, and recordings at right after, treatment with CuPhe (10 mM) for 1 h.
Dotted lines represent zero-current level. The number of trace crossovers is 4
on the left and 0 on the right. Five other oocytes showed similar effects. (B)
Redox control of the slow-gate open probability of the K165C heterodimer
(in C212S background). Shown at upper left is the current reduction of the
heterodimer in ND96 with or without 1.5 mM CuPhe. The oocyte was ﬁrst
incubated in b-ME for at least 1 h. The recording was initially made in the
same b-ME-containing solution. The arrow indicates the time when the
solution was replaced with pure ND96 solution, or ND96 solution with
1.5 mMCuPhe. The current was measured at140 mV using protocol 1, and
the amplitudes were normalized to the current amplitudes just before the
solution exchange. The graph in the upper right corner gives a comparison of
the current reduction rate in the absence or presence of 1.5 mMCuPhe. Time
constants were derived from a single-exponential ﬁt of the recordings like
those shown on the left. The bottom panel shows how inhibition of the
K165C heterodimer, both by spontaneous oxidation and by the applied
CuPhe, could be reversed by the reducing reagent b-ME. The dotted line
represents zero-current level. The oocyte was initially recorded in ND96,
and the redox reagents were applied as shown by the horizontal lines. (C)
Redox control of K165-K165E heterodimer (in C212S background).
Recordings at left were made before, and recordings at right after, 1 h of
CuPhe (10 mM) treatment. Three other oocytes showed similar effects. In
addition, ﬁve oocytes expressing K165-K165H heterodimer (also in C212S
background) also showed similar effects of CuPhe.
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oxidation power was further increased by adding 1.5 mM
CuPhe to the ND96 solution (Fig. 5 B, upper panel).
Furthermore, both the spontaneously oxidized current and
the CuPhe-inhibited current can be recovered by b-ME
treatment with similar time courses (Fig. 5 B, bottom panel),
suggesting that the spontaneous oxidation in ND96 solution
and the CuPhe treatment may exert the same effect in
inhibiting the K165C heterodimer. Besides the K165C
heterodimer, we also examined the K165E heterodimer in
the C212S background mutation, and this mutant was also
sensitive to CuPhe inhibitions (Fig. 5C). These results suggest
that the residue C212 is probably not the target of the redox
reaction responsible for the functional consequence described
above.
Current induction of the K165C heterodimer by
MTS reagents reports the redox state
The redox control of the ClC-0 gating can be further
demonstrated through the modiﬁcation of K165C mutants
by thiol-speciﬁc, MTS reagents. In the K165C homodimer
(in C212S background), MTSET is able to react with the
introduced cysteine, but the ClC-0-like current cannot be
induced (Lin and Chen, 2000). However, the functional
consequence of MTSET modiﬁcation in the K165C hetero-
dimer (also in C212S background) is different. Fig. 6 shows
that MTSET can induce current in the K165C heterodimer.
This effect is due to the modiﬁcation of the only introduced
cysteine residue at position 165 because MTSEA is unable to
induce more current after the channel is treated with MTSET
(data not shown). The rate of current induced by MTSET in
the K165C heterodimer is voltage-sensitive—the apparent
modiﬁcation rate is faster when the monitoring pulse
contains a negative voltage step (Fig. 6 A). Furthermore,
the apparent MTSET modiﬁcation rate is also temperature
sensitive. With an ;10C increase in the bath temperature,
the current induction rate is increased by ;6-fold in a
nominal MTSET concentration of 30 mM (Fig. 6 B). The Q10
value of the MTSET induction rate in Fig. 6 B may be
severely underestimated because of a very high temperature
dependence of the hydrolysis rate of MTS reagents. These
observations point to the possibility that although the
K165C-containing pore in the heterodimer does not become
functional after MTSET modiﬁcation—that is, the fast gate
is not open—the MTSET modiﬁcation may increase the
slow-gate open probability of the heterodimer, thus making
more current ﬂow through the other pore hosting the K165
residue.
If the MTSET modiﬁcation of K165C only affects the
slow gating of the heterodimeric channel and does not open
the fast gate of the MTSET modiﬁed pore, the fast-gate Po-V
curve of the MTSET-modiﬁed heterodimer must be the same
as that of the channel without MTSET modiﬁcation. Fig. 6 C
compares the fast-gate Po-V curves of the heterodimer
between the oocytes treated with MTSET and those reduced
with b-ME. Both curves have a V1/2 similar to that of the
C212S background channel, suggesting that the current of
the oocyte after MTSET modiﬁcation comes from the WT,
K165-containing pore. The other pore containing the
MTSET-modiﬁed K165C is not functional, a conclusion
consistent with the modiﬁcation of MTSET on the K165C
homodimer. These results together suggest that the induction
of the current in the K165C heterodimer by MTSET is due to
the increase of the slow-gate open probability.
The modiﬁcation of the K165C heterodimer with MTSET
and the other MTS reagent, MTSEA, also depends on the
redox state of the oocyte. Fig. 7 compares the current
induction by MTS reagents in the K165C heterodimer with
or without b-ME pretreatment. After the oocyte is incubated
in b-ME for more than 30–60 min, the slow gate of the
FIGURE 6 Current induction of the K165C heterodimer by MTSET. (A)
Voltage dependence of the current induction. The oocyte current was
monitored by the voltage pulse shown on the right. The indicated voltages
were the potentials applied during the pulse. Each circle represents the
current amplitude measured at the end of the 140 mV voltage step. Arrows
indicate the time point at which 30 mM MTSET was applied. (B)
Temperature dependence of the current induction. Oocyte current was
monitored by the pulsing protocol as in the bottom panel of A, and each
circle is the current measured at the end of the 140 mV voltage step. All
oocytes in A and B were incubated in ND96 without b-ME for at least 2 h
before the experiments. (C) Comparison of the fast-gate Po-V curves of the
MTSET and b-ME-treated K165C heterodimers. Data points were the
average of three independent measurements. MTSET, 100 mM; b-ME,
2 mM. The solid and dotted curves were drawn according to a Boltzmann
equation: Po ¼ Pmin 1 (1  Pmin)/[1 1 exp(zF(V  V1/2)/RT)], with
Pmin ¼ 0.15. The values of V1/2 and z were: 83 mV and 0.77, respectively,
for b-ME (circles), and 86 mV and 0.89 for MTSET (squares).
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K165C heterodimer is more easily opened by the negative
voltage step of protocol 1. Under such conditions, MTSET
cannot further induce current (Fig. 7 A, right). By com-
parison, when the oocyte was not pretreated with reducing
reagents, MTSET could induce current from the K165C
heterodimer (Fig. 7 A, left; for averaged data, see Fig. 7 C).
Modiﬁcation of the introduced cysteine in the K165C
heterodimer by MTSEA makes the K165C-containing pore
functional (Lin and Chen, 2000), but the fold increase of the
current induced by MTSEA depends on the redox state of the
oocyte as well (Fig. 7 B; for averaged data see Fig. 7 D).
When the oocyte is preincubated with b-ME, the current
after MTSEA treatment is usually ;2-fold that before the
MTSEA modiﬁcation (Fig. 7 D), reﬂecting the functional
revival of the other pore by MTSEA with little change of the
slow-gate open probability (Fig. 7 B, right). In comparison,
when oocytes are not pretreated with b-ME, the current after
MTSEA modiﬁcation can be as high as 10-fold (mean 6
SE ¼ 5.16 0.6) that before the application of MTSEA (Fig.
7 B, left). These experiments suggest that in the absence of
b-ME, oxidation of the oocyte may have rendered the slow
gate of the heterodimer more difﬁcult to open. Therefore,
MTSET or MTSEA are able to induce more current because
the channel has a higher slow-gate open probability after
MTS modiﬁcation.
DISCUSSION
We have shown that oxidation and reduction can control the
inactivation gating of ClC-0. In the oxidized condition, the
channel appears to be at a ‘‘deep’’ inactivated state, and
the channel’s slow gate is more difﬁcult to open by negative
voltage pulses. Only when the membrane potential is stepped
to a very negative potential, for example,120 to160 mV,
can a small portion of the channel recover from this deep
inactivated state. Thus, an oxidized oocyte would not show
a nice deactivation relaxation because of two opposite
effects: a reduction of the current due to the fast-gate closure
and an increase of current due to the slow-gate opening by
the very negative potentials. This understanding is signiﬁ-
cant in studying ClC-0 because expression of ClC-0 in
Xenopus oocytes frequently generates hyperpolarization-
induced current. One might consider that such atypical
recordings perhaps result from the contamination of the
endogenous Cl channels of the oocyte. Our study, however,
indicates that when ClC-0 is expressed in Xenopus oocytes,
the hyperpolarization-induced current does not necessarily
come from the endogenous Cl channels. In our experi-
ence, incubation of the oocytes in reducing agents, such as
2–5 mM b-ME or DTT, for 30 min or longer always turns
the atypical traces into typical ClC-0 recordings that show
crossovers of traces at negative voltages (Fig. 2).
The oxidation effect on the slow gating of the WT ClC-0
is slow and is rather difﬁcult to study. By simply removing
reducing agents in the solution, the current of WT ClC-0 can
decrease, but the extent of the current reduction usually
varies quite signiﬁcantly from oocyte to oocyte, depending
on the variation between frogs (Table 1). Application of
oxidizing reagents (CuPhe or H2O2) increases this oxidizing
power. This oxidation effect can be observed in the K165C
heterodimer as well as in the WT ClC-0. Through com-
parison of the MTS modiﬁcations between the oxidized and
reduced conditions, we found that the extent of current
induction in the K165C heterodimer by the MTS reagents
can be used to report the redox state. This conclusion is
based on the observation that MTS modiﬁcation of the
cysteine at position 165 alters the inactivation gating of the
channel. Previous studies have argued that the side chain of
residue 165 is important for the inactivation mechanism of
ClC-0 because the K165C heterodimer shows prominent
inactivation even though this heterodimer is constructed in
the background of C212S (Lin and Chen, 2000), a mutation
FIGURE 7 Effects of oxidation on the current induction of the K165C
heterodimer by MTSET and MTSEA. (A and B) Induction of current in the
K165C heterodimer by 30 mM MTSET and 3 mM MTSEA in oocytes
without (left) or with (right) b-ME pretreatment. Each circle represents the
current amplitude measured at the end of the 140-mV voltage step in
protocol 1. (Insets) Whole oocyte current recordings before (indicated by b)
and after (indicated by a) the application of MTS reagents. Each trace is an
average of three traces made during the period indicated by short line
segments. (C and D) Ratios of the current amplitudes of the heterodimer
before and after the treatment of MTS reagents in oxidized (b-ME) and
reduced (1b-ME) conditions. Note that in the reduced condition (also see
right panel in both A and B), the current of the oocyte after MTSEA
treatment is ;2-fold that before MTSEA induction (Ia/Ib ﬃ 2). MTSET did
not induce current (Ia/Ib ﬃ 1) in reduced oocytes.
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that suppresses the inactivation state of ClC-0 (Lin et al.,
1999). The study described here further demonstrates that
when the introduced cysteine of the K165C heterodimer is
modiﬁed by MTSEA or MTSET, the open probability of the
inactivation gate is increased (Figs. 6 and 7), as supported by
the following observations. First, the MTSET modiﬁcation
rate of the heterodimer is both voltage- and temperature-
sensitive, and the voltage and temperature dependencies
corroborate with those found in the slow gating of ClC-0
(Fig. 6, A and B). Second, the fast-gate Po-V curves of the
heterodimers with or without MTSET modiﬁcation are the
same (Fig. 6 C), a phenomenon different from the situation
where the modifying reagent is MTSEA (Lin and Chen,
2000). Finally, in the manipulations that can maximally
activate the slow gate—for example, recording b-ME-pre-
treated oocytes at low temperatures with a pulsing protocol
containing a negative voltage step (protocol 1)—MTSET is
unable to induce current in the heterodimer, whereasMTSEA
induces exactly twofold current (Fig. 7). These results
together suggest that modiﬁcation of the introduced cysteine
by MTSET or MTSEA increases the slow-gate open
probability of the heterodimer. From the opposite angle, the
different extent of current induction by MTSET and MTSEA
in the oxidized and reduced conditions provides clear evi-
dence that the inactivation gating of ClC-0 depends on the
redox state of the oocyte.
The mechanisms underlying the oxidation effects on ion
channels are variable. Previous studies have shown that the
M448C mutant of the Shaker K1 channel is not functional
when the channel is expressed in Xenopus oocytes incubated
in ND96, but the mutant can be functionally recorded in
reduced environments (Gross and MacKinnon, 1996). The
oxidation effect is attributed to a disulﬁde-bond formation
between the two 448C residues (Liu et al., 1996), an effect
consistent with the picture in which the four residues at
position 448 are close to each other in the outer vestibule of
the channel pore (Doyle et al., 1998). An oxidation effect
was also demonstrated in a G-protein-coupled inwardly
rectifying K1 (GIRK) channel in which the GIRK current
was increased when reducing agents (such as DTT) were
applied (Zeidner et al., 2001). In this case, a cysteine residue
at the N-terminal cytoplasmic domain is responsible for the
redox regulation (Zeidner et al., 2001). For ClC-0, what is
the target for the oxidation chemistry responsible for the
effect on the inactivation gating?
If the side chain of residue 165 is important in controlling
the gating of ClC-0, it might be possible that the oxidation-
reduction occurs on the K165C residue, explaining the
oxidation effect in the K165C mutant. Stable cysteine-
sulfenic acid (Cys-SOH) derivatives have been observed in
redox regulation of enzyme catalysis (Claiborne et al., 1999;
van Montfort et al., 2003; Wang et al., 2004). It might be
plausible that oxidation of K165C results in a side chain with
a sulﬁnic (SO2 ) or sulfonic (SO

3 ) group, both carrying
a negative charge. However, because the oxidized and
reduced K165C mutants have comparable MTSEA induction
rates (within twofold difference, data not shown), we think
this possibility is less likely because a reaction of the above
oxidized sulfonyl groups with MTSEA should be much
slower than the MTS modiﬁcation of a free thio group.
Furthermore, the K165E heterodimer suggests that a cysteine
at K165 position is not required for the oxidation effect (Fig. 5
C). We therefore suggest that oxidation should occur at sites
other than the K165C residue. Cysteinemutation experiments
showed that only mutants lacking the cysteine at position 212
were resistant to CuPhe inhibition (Fig. 4). However, the
oxidation effect should not be due to a disulﬁde bond
formation between these two cysteines because a C212S-
C212 heterodimer is still sensitive to CuPhe inhibition (Fig. 5
A). The residues of the bacterial ClCmolecule that correspond
to C212 of ClC-0 are buried in the middle of each of the two
protein subunits, and they are tens of A˚ away from each other.
Therefore, structural information from bacterial ClCs argues
that the disulﬁde bond formation between the two C212
residues is rather unlikely. We further suggest that the
oxidation target may not be the residue C212, because both
the K165C and K165E heterodimers are constructed in the
C212S background mutation, and the redox effects in these
mutants are still present. Therefore, the resistance of the
C212S mutant to CuPhe inhibition most likely results from
the absence of inactivation state instead of the elimination of
the oxidation target. This conclusion is analogous to the
explanation for the resistance of the C212S mutant to
extracellular zinc inhibition (Lin et al., 1999).
Although we have documented a redox control on the
inactivation gating of ClC-0, our understanding of this effect
is incomplete in several respects. First, we have so far not
identiﬁed the target for the oxidation-reduction reaction.
Thus, we do not know if the effect is due to an oxidation of
the channel protein or perhaps due to the oxidation of endo-
genous protein molecules, or even the lipids of the oocyte
membrane. Second, we do not understand how the inac-
tivation gating of ClC-0 is controlled by the redox state of the
oocyte except for the ﬁnding that the inactivation-suppressed
mutant is resistant to oxidation inhibition. Finally, although
we have noted that the oxidized ClC-0 current is more fre-
quently encountered in the oocytes from older-aged frogs,
we do not know precisely how the oocyte quality is related to
the variation of the current. However, even with these unan-
swered questions, our study illustrates the redox control on
the ClC-0 inactivation, and shows that the atypical ClC-0
current in Xenopus oocytes can be ‘‘cured’’ by reducing
reagents. This discovery should be helpful in functional
studies of ClC-0, at least in the experiments using Xenopus
oocytes as the expression system.
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